The DOI matches its Crossref record.
Indications of the Mechanisms Involved in Improved Sperm Parameters by Zinc Therapy
Abstract
Objective: To determine possible indications of the mechanisms involved in improved sperm parameters by zinc therapy in asthenozoospermic men. Subjects and Methods: Forty-five men with asthenozoospermia (≧40% immotile sperm) were randomized into four therapy groups: zinc only: n = 11; zinc + vitamin E: n = 12 and zinc + vitamins E + C: n = 14 for 3 months, and non-therapy control group: n = 8. Semen analysis was done according to WHO guidelines. Malone dialdehyde, tumour necrosis factor-α (TNF-α), total antioxidant capacity, superoxide dismutase (SOD) and glutathione peroxidase were determined in the semen and serum. Antisperm antibodies IgG, IgM and IgA were evaluated by immunobeads. Sperm chromatin integrity was determined by acid denaturation by acridine orange and sperm apoptosis by light and electron microscopy. The effect of zinc on in vitro induced sperm oxidative stress by NADH was evaluated. Results: Asthenozoospermia was significantly associated with oxidative stress with higher seminal malone dialdehyde (8.8 vs. 1.8 mmol/l, p < 0.001) and TNF-α (60 vs. 12 pg/l, p < 0.001), and low total antioxidant capacity (1.8 vs. 8.4, p < 0.01), SOD (0.8 vs. 3.1, p < 0.01) and glutathione peroxidase (1.6 vs. 4.2, p < 0.05), compared to normozoospermia. Zinc therapy alone, in combination with vitamin E or with vitamin E + C were associated with comparably improved sperm parameters with less oxidative stress, sperm apoptosis and sperm DNA fragmentation index (DFI). On the whole, there was no difference in the outcome measures between zinc only and zinc with vitamin E and combination of vitamins E + C. In the in vitro experiment zinc supplementation resulted in significantly lower DFI (14–29%, p < 0.05) compared to zinc deficiency. Conclusion: Zinc therapy reduces asthenozoospermia through several mechanisms such as prevention of oxidative stress, apoptosis and sperm DNA fragmentation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Oxidative stress and male infertility—a clinical perspective
Tremellen, K. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn004 · Cited by 1,507
Gharagozloo, P., & Aitken, R. J. (2011) · Human Reproduction · doi:10.1093/humrep/der132 · Cited by 522
Barratt, C. L. R., Björndahl, L., De Jonge, C. J., Lamb, D. J., Osorio Martini, F., McLachlan, R., Oates, R. D., van der Poel, S., St John, B., Sigman, M., et al. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx021 · Cited by 505
“Two studies showed improvements in sperm DNA integrity after herbal therapy (Omu et al. 2008; Raigani et al. 2014).”
BackgroundSperm DNA Fragmentation: A New Guideline for Clinicians
Agarwal, A., Majzoub, A., Baskaran, S., Panner Selvam, M. K., Cho, C. L., Henkel, R., Finelli, R., Leisegang, K., Sengupta, P., Barbarosie, C., et al. (2020) · The World Journal of Men's Health · doi:10.5534/wjmh.200128 · Cited by 316
Antioxidants for male subfertility
Showell, M. G., Brown, J., Yazdani, A., Stankiewicz, M. T., & Hart, R. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007411.pub2 · Cited by 307
Etiologies of sperm oxidative stress
Sabeti, P., Research and Clinical Center for Infertility, S. S. U. O. M. S., Pourmasumi, S., Research and Clinical Center for Infertility, S. S. U. O. M. S., Rahiminia, T., Research and Clinical Center for Infertility, S. S. U. O. M. S., Akyash, F., Research and Clinical Center for Infertility, S. S. U. O. M. S., Talebi, A. R., & Research and Clinical Center for Infertility, S. S. U. O. M. S. (2016) · International Journal of Reproductive BioMedicine · doi:10.29252/ijrm.14.4.231 · Cited by 299
Antioxidants for male subfertility
Showell, M. G., Mackenzie-Proctor, R., Brown, J., Yazdani, A., Stankiewicz, M. T., & Hart, R. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007411.pub3 · Cited by 285
Antioxidants for male subfertility
Smits, R. M., Mackenzie-Proctor, R., Yazdani, A., Stankiewicz, M. T., Jordan, V., & Showell, M. G. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007411.pub4 · Cited by 277
The role of antioxidant therapy in the treatment of male infertility
Agarwal, A., & Sekhon, L. H. (2010) · Human Fertility · doi:10.3109/14647273.2010.532279 · Cited by 275
A systematic review of the effect of oral antioxidants on male infertility
Ross, C., Morriss, A., Khairy, M., Khalaf, Y., Braude, P., Coomarasamy, A., & El-Toukhy, T. (2010) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2010.03.008 · Cited by 265
Molecular Changes Induced by Oxidative Stress that Impair Human Sperm Motility
Nowicka-Bauer, K., & Nixon, B. (2020) · Antioxidants · doi:10.3390/antiox9020134 · Cited by 264
Steiner, A. Z., Hansen, K. R., Barnhart, K. T., Cedars, M. I., Legro, R. S., Diamond, M. P., Krawetz, S. A., Usadi, R., Baker, V. L., Coward, R. M., et al. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.11.008 · Cited by 213
“Although benefits of vitamin C (15), selenium (9), N-acetylcysteine (10), L-carnitine (16), and zinc (17) on sperm motility have been found after 3 months of treatment, most of those studies were small and heterogeneous.”
BackgroundLi, K.-P., Yang, X.-S., & Wu, T. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.810242 · Cited by 79
“Omu 2008 (49) Kuwait Open 35 ± 1 Zinc 400 mg (n = 11) 3 months 12 Infertile men with iA, normal sperm concentration (20 to 250 million/ml) but with 40% or more immotile sperm PL (n = 8) per day Boonyarangkul 2015 (50) Thailand Doubleblind Folic: 26.”
BackgroundInfluential
Metadata
- Authors
- Omu, A. E., Al-Azemi, M. K., Kehinde, E. O., Anim, J. T., Oriowo, M. A., & Mathew, T. C.
- Venue
- Medical Principles and Practice
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 17
- Issue
- 2
- Pages
- 108-116
- ISSN
- 1011-7571 (ISSN-L)
- 1423-0151
- OpenAlex
- W1966316717
- Cited by
- 191
- References
- 0
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.